About JAMES A CHARLES MD, FAAN, FAHS
CREDENTIALS
Accepting new patients: I am accepting new patients.
Primary Specialty: Neurology
Secondary Specialty: Clinical Neurophysiology/Electrodiagnostic Medicine/Headache Medicine
Undergraduate Education: St Peter's College, 1974 BS in BIOLOGY
Medical Education: Doctor of Medicine: 1978; New Jersey (Rutgers) Medical School
Academic Appointments: Clinical Associate Professor of Neurology : 2007 Adjunct teaching faculty-Rutgers-New Jersey Medical School-Department of Neurology
Languages other than English: Spanish
In Practice Since: 1982
- Neurology : 1979-1982
- University Hospital Health System and affliates; Chief Resident 1982
- Medicine : 1979
- 1978-1979 Internship in Medicine , Hackensack University Medical Center, Rotating Internship
- UCNS-United Council Neurological Subspecialties, Headache Medicine, Certified 2006, Recertified 2016
- Added Qualifications in Clinical Neurophysiology- American Board of Psychiatry/Neurology NEUROLOGY, Certified 2006, Recertified in 2016
- American Board of Electrodiagnostic Medicine, Certified 1989
- American Board of Psychiatry and Neurology (NEUROLOGY), Certified 1984
- Top Doctors: New York Metro Area (book series): 11th Edition, 12th Edition, 13th Edition, 14th Edition, 15th Edition, 16th Edition, 17th Edition, 18th Edition Jersey's
- Best Magazine Top Doctors: 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022
- Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022
- New York Magazine: Top Doctors: 2021, NJ Monthly October 2014 Top Doctor
- Charles JA. Treatment of Painful Peripheral Neuropathy with Erenumab - An Observational Study. J Clin Neurol Neurosurgery Spine. 2022; 5(1): 1023.
- Charles J, Suttora N. Recurrence of Acute Migraine Following Ubrogepant and Diclofenac Buffered Solution Combination Therapy-An Observational Study, Journal of Pharmaceutical Research . Volume 3(1): 3-3 Journal of Pharmaceutical Research; April 2022
- Charles JA, Turner IM, AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost? HEADACHE; pages 109-110 ; Volume 62 issue 1 2022
- Charles, J Letter to the Editor; In support of CGRP mAb therapy in refractory pediatric migraine; HEADACHE, Jan 2020Charles, J Treatment of postraumatic headache migraine phenotype with erenumab- An observational study. Journal of Concussion, Volume 3: 1-4, 2019
- Charles J, Rapoport A. Comment, Observations, and Rebuttal; The American Headache Society’s Position Statement on Integrating New Migraine Treatments Into Clinical Practice. HEADACHE, Volume 59, Issue 4, April 11, 2019
- Charles J. Consideration of Costs and Open-label Studies of Erenumab. JAMA Neurology, 2019;76(2):236
- Charles JA, Righthand R, Avenoso P. Fatal myocardial infarction due to rituximab in the treatment of IgG4 related disease-another case, tip of the iceberg? Journal of Cancer Ther and Research, Aug 1, 2018
- Charles JA, Gallo, V. Ketamine Plus Memantine-Based Multimodality Treatment of Chronic Refractory Migraine. Neurology Review, July 2018.
- Allen BB, Charles JA, Papadopoulos E, Avila EK. Neurogenic Orthostatic Hypotension with Critical Illness Neuropathy Treated with Droxidopa. Autonomic Neuroscience, July 2016
- Charles JA, Souayah N. Critically re-evaluating a common technique.: Accuracy, reliability, and confirmation bias of EMG. letter to editor, NEUROLOGY, 3-7-2016
- Charles JA. Improving referring physicians' understanding of electromyography reports. Muscle and Nerve, vol 49, no.5, p 772, May 2014
- Charles, JA. Roadblock to the only FDA approved Treatment for Chronic Migraine. Headache, Journal of Head and Face pain. Vol 54. Jan.2014
- Charles JA. Disease-Modifying Drugs for Multiple Sclerosis in Pregnancy: A Systemic Review-Correspondence Neurology, March 2013
- Charles JA, Souayah N. EMG/NCS in the Evaluation of Spine Trauma with Radicular Symptoms. Neurol Clin Pract 2013; 3; 8
- Charles, JA. Pathophysiology of Chronic Migraine and Mode of Action of Preventive Medications: A Comment. Journal of Headache and Face Pain, Vol 51 (10), Nov/Dec 2011
- Charles, JA. Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties ; clinical neurophysiology. Correspondence. Neurology, December 21, 2010
- Charles JA. Use of DMD Glatiramer up to conception. Correspondence to: Pregnancy and Childbirth in Women with MS, Journal Watch. February 2010; publisher New England Journal of Medicine
- Charles JA, Vondohln P. Outpatient Home-Based Continuous Intravenous Dihydroergotamine Therapy for Intractable Migraine. Journal of Headache and Pain. May 2010
- Charles JA, Peterlin BL, Rapoport AM. Early Treatment of New Onset Child and Adolescent Migraine May Prevent Disease Progression. Neurology Reviews. December 2009, p 20
- Charles JA, Peterlin BL, Rapoport AM. Chronic Daily Headache in Adolescents: An 8 year follow-up study. Correspondence. Neurology 2009, Sept 16
- Charles JA, Peterlin B Lee, Rapoport A, Linder SL, Kabbouche MA, Sheftell F. Favorable Outcome of Early Treatment of New Onset Child and Adolescent Migraine-Implications for Disease Modification.The Journal of Headache and Pain: Volume 10, Issue4 (2009), Page 227.
- Charles JA, Kamin S, et al. Neurodiagnostic Challenge: Hemorrhagic Tumor or Something Else? Applied Neurology, December 2007, pp31-33.
- Charles, JA. Early treatment of juvenile migraine reduces disability with disease modification implications. Journal of Headache and Pain; April 2007.
- Charles. JA. Principles of Neurology and Electrodiagnostic Testing. NJ Lawyer magazine; Oct, 2006.
- Charles, JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old-a study of efficacy and safety. Journal of Headache and Pain, April, 2006.
- Charles JA, Kamin S, Weisholz S, Fontana L, Moore F, Hollywood J, Kashani M. Enteroccocus brain abscess related to piperacillin/tazobactam with radiographic appearance of a neoplasm. Infections in Medicine; Vol 24, No.4, April 2007.
- James A Charles MD, FAAN; Seymour Jotkowitz MD,; Lawrence H Byrd MD. "Prophylactic treatment of migraine with olmesartan in patients with hypertension/prehypertension". Headache, 2006;46:503-507.
- James A Charles, MD, FAAN, Patricia von Dohln, RN. Outpatient intravenous dihydroergotamine for refractory headache. Headache, 45:4:4, April 2005
- James A Charles, MD; Patrick M Pullicino, MD, PhD, Paul M Stoopack, MD, Yogini Shroff, MD. Ischemic colitis associated with naratriptan and oral contraceptive use. Headache, 45:4:1-3, April 2005
- Charles, JA; Jotkowitz, S. "Observations of the "carry-over effect" following successful termination of chronic migraine in the adolescent with short term dihydroergotamine, dexamethasone, and hydroxyzine-a pilot study. Journal of Headache and Pain, 6:51-54, February 2005.
- James A. Charles MD; Mark Berger MD; and Stuart D. Cook MD. Thoracic syringomyelia and suspected multiple sclerosis: Cause and effect or coincidence? Neurology,63, 185-186, July 2004
- Bogden J; Lintz D; Charles JA; Salaki J. Effect of Pulmonary Tuberculosis on Blood Concentrations of Copper and Zinc. Amer J Clin Path 67:251, 1977
- Basteck J; Bogden J; Cinotti D; Charles JA. Trace metals in a family with Sex Linked Retinitis Pigmentosa. Retinitis Pigmentosa, 1976 Plenum Pub Co. New York
- Holy Name Medical Center : 2012 -present
- Clinical Associate Professor of Neurology-NJ/Rutgers Medical School : as of 2007; (Clinical Assistant Professor Rank 1985-2006)
Copyright © 2022 - All Rights Reserved. Powered by GEON SOLUTIONS
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.